NVAX Novavax, Inc. Stock Quote

NVAX [NASD]

Index	-	P/E	-	EPS (ttm)	-5.22	Insider Own	0.10%	Shs Outstand	63.66M	Perf Week	0.73%
Market Cap	8.12B	Forward P/E	7.09	EPS next Y	17.64	Insider Trans	-86.59%	Shs Float	62.92M	Perf Month	-5.09%
Income	-272.50M	PEG	-	EPS next Q	-1.31	Inst Own	50.70%	Short Float	11.65%	Perf Quarter	22.54%
Sales	204.80M	P/S	39.65	EPS this Y	44.90%	Inst Trans	0.53%	Short Ratio	1.77	Perf Half Y	-11.12%
Book/sh	1.73	P/B	72.28	EPS next Y	421.30%	ROA	-45.90%	Target Price	188.50	Perf Year	1173.42%
Cash/sh	7.76	P/C	16.11	EPS next 5Y	0.00%	ROE	-	52W Range	6.26 - 189.40	Perf YTD	12.14%
Dividend	-	P/FCF	164.03	EPS past 5Y	5.60%	ROI	-	52W High	-33.19%	Beta	1.81
Dividend %	-	Quick Ratio	2.80	Sales past 5Y	-9.50%	Gross Margin	-	52W Low	1921.46%	ATR	10.42
Employees	165	Current Ratio	2.80	Sales Q/Q	6163.40%	Oper. Margin	-	RSI (14)	54.15	Volatility	7.48% 8.81%
Optionable	Yes	Debt/Eq	4.14	EPS Q/Q	-332.20%	Profit Margin	-	Rel Volume	0.65	Prev Close	125.05
Shortable	Yes	LT Debt/Eq	3.62	Earnings	Nov 09 AMC	Payout	-	Avg Volume	4.15M	Price	126.54
Recom	2.40	SMA20	3.54%	SMA50	10.70%	SMA200	37.21%	Volume	1,283,745	Change	1.19%

Dec-14-20

Initiated

Jefferies

Buy

$200

Aug-06-20

Reiterated

H.C. Wainwright

Buy

$132 → $290

Aug-05-20

Upgrade

JP Morgan

Neutral → Overweight

$275

Aug-05-20

Downgrade

Ladenburg Thalmann

Neutral → Sell

$105

Jul-16-20

Reiterated

H.C. Wainwright

Buy

$101 → $132

Jul-08-20

Downgrade

Ladenburg Thalmann

Buy → Neutral

$50 → $105

Jun-29-20

Reiterated

H.C. Wainwright

Buy

$50 → $101

Jun-29-20

Reiterated

B. Riley FBR

Buy

$74 → $106

Jun-05-20

Upgrade

JP Morgan

Underweight → Neutral

$46

May-28-20

Reiterated

B. Riley FBR

Buy

$53 → $61

May-12-20

Reiterated

H.C. Wainwright

Buy

$33 → $50

Apr-30-20

Reiterated

H.C. Wainwright

Buy

$24 → $33

Nov-27-19

Resumed

B. Riley FBR

Buy

$12

Aug-14-19

Reiterated

H.C. Wainwright

Buy

$10 → $17

Feb-28-19

Downgrade

Piper Jaffray

Overweight → Underweight

$4.50 → $0.25

Dec-18-18

Initiated

Ladenburg Thalmann

Buy

Dec-11-18

Initiated

Oppenheimer

Outperform

Nov-26-18

Upgrade

Piper Jaffray

Neutral → Overweight

Sep-21-18

Upgrade

JP Morgan

Underweight → Overweight

Mar-29-18

Upgrade

Seaport Global Securities

Neutral → Buy

Jan-20-21 02:08PM	Top Small Cap Stocks for February 2021 Investopedia
Jan-19-21 11:05PM	S.Korea may secure additional COVID-19 vaccines from Novavax, Moon says Reuters
08:37AM	AstraZeneca's (AZN) Enhertu Gets FDA Nod for Gastric Cancer Zacks
Jan-15-21 05:50PM	Novavax (NVAX) Dips More Than Broader Markets: What You Should Know Zacks
12:56PM	Why Moderna Has More Upside Than Its Covid-19 Vaccine Implies InvestorPlace
12:47PM	Novavax Hires Regulatory Expert As Coronavirus Vaccine Inches Closer To Emergency Use Filing Benzinga
10:51AM	Is Novavax Stock A Buy As Pressure Mounts For A Covid-19 Vaccine? Investor's Business Daily
08:18AM	Make a Fortune With These 4 High Earnings Yield Picks Zacks
08:00AM	Regulatory Expert Henrietta Ukwu, M.D. Appointed Novavax Chief Regulatory and Quality Officer GlobeNewswire
Jan-14-21 04:55PM	Pfizer Leads Vaccine Stocks As The Most Trusted Name In Covid-19: IBD/TIPP Investor's Business Daily
12:27PM	Want to Use ETFs to Play Biotech? Choose Wisely. Barrons.com
Jan-13-21 09:42AM	3 Biotech Stocks Poised to Outperform Amid Coronavirus Pandemic Zacks
08:36AM	ERYTECH Pharma (ERYP) Catches Eye: Stock Jumps 7.4% Zacks
06:05AM	My Best Coronavirus Stock for 2021 Motley Fool
Jan-12-21 09:09AM	Baxter (BAX) Inks Sterile Manufacturing Agreement With Novavax Zacks +6.58%
08:54AM	Is the Options Market Predicting a Spike in Novavax (NVAX) Stock? Zacks
Jan-11-21 07:37PM	Why Novavax Fell by Over 4% Today Motley Fool
12:29PM	BioNTech CEO Says a Version of Its Covid Vaccine With Less Stringent Storage Requirements Could Come This Year Barrons.com
07:00AM	INSIGHT-Novavax bosses cash out for $46 mln with COVID-19 vaccine trials still under way Reuters
Jan-10-21 07:06AM	My Best Coronavirus Vaccine Stock for 2021 Motley Fool
06:06AM	3 Top Biotech Picks for 2021 Motley Fool
Jan-08-21 11:50AM	Novavax Strikes Another Coronavirus Vaccine Supply Deal: Where Does The Company's Program Stand? Benzinga
10:41AM	As Competition Rises, the Bull Case for Moderna Stock Is Beginning to Fade InvestorPlace
09:36AM	Under-the-Radar Novavax Can Still Make a Splash InvestorPlace
08:42AM	Pfizer-BioNTech Vaccine Effective Against Mutation in New Covid-19 Variants, Study Finds Barrons.com
07:25AM	The Daily Biotech Pulse: Sarepta Gene Therapy Study Readout, Novavax Vaccine Supply Deal, 2 IPOs Benzinga
06:05AM	2 COVID Stocks That Turned $100,000 Into Well Over $1 Million in 2020 Motley Fool
Jan-07-21 06:14PM	Novavax Finalizes Agreement with Commonwealth of Australia for 51 Million Doses of COVID-19 Vaccine GlobeNewswire
06:30AM	The 10 Best-Performing Stocks of 2020 Motley Fool
06:10AM	Forget Bitcoin: This Stock Is a Better Buy Motley Fool
Jan-06-21 04:10PM	3 Things to Expect from Novavax in 2021 Motley Fool +6.45%
11:07AM	2021 Could Be Novavax's Year Benzinga
09:15AM	Novavax Has Covid-19 Vaccine News Coming Out Soon. That Could Be Good for the Stock. Barrons.com
09:00AM	Novavax to Participate in Upcoming Conferences GlobeNewswire
Jan-04-21 06:28PM	The Worst Mistake Novavax Investors Can Make Right Now Motley Fool
10:18AM	Outlook for biotech companies in 2021 Yahoo Finance Video
Jan-03-21 06:11AM	3 Coronavirus Stocks Poised to Soar in 2021 Motley Fool
Jan-02-21 06:36AM	3 Healthcare Stocks That Turned $100,000 Into $1 Million in 2020 Motley Fool
Jan-01-21 06:10AM	These Were the 3 Best Coronavirus Stocks of 2020 Motley Fool
Dec-31-20 08:09AM	Investors in This One Stock Had an Amazing Year Motley Fool -6.26%
06:31AM	Novavax Is Inching Closer, But Its Vaccine Better Be Special InvestorPlace
Dec-30-20 11:40AM	Biotech Stock Roundup: REGN Provides COVID-19 Updates, MYOV Partners With PFE & More Zacks
06:51AM	If You Invested $1,000 in Novavax in January, This Is How Much Money You'd Have Now Motley Fool
06:45AM	Why Is Everybody Talking About Novavax Stock? Motley Fool
01:04AM	Indonesia says agreements signed for 100 mln doses of coronavirus vaccine Reuters
Dec-29-20 06:19PM	Novavax Stock Is up Over 2,900% This Year. How Much Higher Can It Go? TipRanks
05:11PM	Novavax Starts a Phase 3 Trial for Its Covid Vaccine, While Arcturus Gets 5 Downgrades for Its Stock Barrons.com
10:12AM	Novavax (NVAX) Initiates Phase III Study on COVID-19 Vaccine Zacks
09:34AM	Novavax's Charts Get a Shot in the Arm TheStreet.com
09:33AM	Three More Coronavirus Vaccines Expected by Early 2021 Barrons.com
09:01AM	Boeing 737 MAX, $2,000 Checks, Novavax Vaccine - 5 Things You Must Know Tuesday TheStreet.com
08:38AM	Boeing, Apple, Cisco, Novavax - Tuesday's Premarket Movers TheStreet.com
Dec-28-20 06:13PM	Why Novavax Stock Got Crushed Today Motley Fool -9.66%
02:21PM	Novavax Starts a Late-Stage Coronavirus Vaccine Clinical Trial Motley Fool
11:27AM	Novavax Launches Phase 3 Trial of Covid-19 Vaccine Candidate TheStreet.com
09:31AM	Novavax starts Phase 3 COVID vaccine trial with plans to enroll 30,000 volunteers in U.S. and Mexico MarketWatch
09:21AM	Novavax Announces Initiation of PREVENT-19 Pivotal Phase 3 Efficacy Trial of COVID-19 Vaccine in the United States and Mexico GlobeNewswire
09:19AM	What Does Novavax's Debt Look Like? Benzinga
09:15AM	Novavax starts late-stage trial of COVID-19 vaccine in United States Reuters
06:06AM	4 Fast-Growing Stocks Billionaires Can't Stop Buying Motley Fool
Dec-27-20 06:11AM	3 COVID Vaccine Stocks Smart Investors Are Buying for 2021 Motley Fool
Dec-26-20 07:30AM	Year of the Meme Stock: Hertz, Kodak Top List of 2020 Highlights Bloomberg
07:05AM	Is Novavax Stock a Buy? Motley Fool
Dec-24-20 12:12PM	Vaccine Stocks Rebound On Pfizer's U.S. Deal, Moderna OK In Canada Investor's Business Daily
06:14AM	Novavax vs Inovio: Which Covid-19 Play Is A More Compelling Investment? TipRanks
06:14AM	3 Great COVID Vaccine Stocks to Buy Right Now Motley Fool
Dec-23-20 02:01PM	We dont know yet what caused this mutation: Doctor on new strain of coronavirus Yahoo Finance Video +10.64%
Dec-22-20 02:41PM	Fair to say new coronavirus strain is in the U.S.: Doctor Yahoo Finance Video -7.00%
01:35PM	The new coronavirus strain may infect and spread faster:' Doctor Yahoo Finance Video
10:35AM	How Worrisome Is This U.K. Virus Variant? Bloomberg
09:53AM	Is NVAX A Good Stock To Buy According To Hedge Funds? Insider Monkey
06:48AM	Is There Still Room for Growth for These 2 Coronavirus Stocks? Motley Fool
Dec-21-20 05:42PM	Biopharma Executive Rick Crowley Joins Novavax as Chief Operations Officer GlobeNewswire
11:55AM	Got $600? Here Are 3 Hot Stocks to Buy Before 2021 Motley Fool
09:00AM	Year-End Portfolio Tweaks for an Unusual Year Bloomberg
05:51AM	5 High-Growth Stocks That Crushed Bitcoin in 2020 Motley Fool
Dec-20-20 06:09AM	3 Incomparable Coronavirus Vaccine Stocks to Buy Right Now Motley Fool
Dec-19-20 06:33AM	Where Will Novavax Be in 1 Year? Motley Fool
06:09AM	3 Top Biotech Stocks to Buy Right Now Motley Fool
Dec-18-20 04:47PM	Is This the Sell the News Moment for Moderna Stock? InvestorPlace -5.24%
11:30AM	Novavax will have the capacity for two billion doses of COVID-19 vaccine globally: Novavax Board Member Yahoo Finance Video
07:22AM	4 Small COVID-19 Vaccine Makers to Look Out for in 2021 Zacks
Dec-17-20 12:25PM	Novavax Clinches 10.7M-Dose Coronavirus Vaccine Supply Deal With New Zealand Benzinga +8.99%
07:00AM	How Many Different Covid-19 Vaccines Do We Need? Bloomberg
07:00AM	Real thing or placebo? My COVID-19 vaccine odyssey continues Reuters
06:09AM	EU concludes preliminary talks to buy up to 200 mln doses of Novavax COVID vaccine Reuters
Dec-16-20 07:25PM	Novavax enters deal with New Zealand for 10.7M doses of COVID-19 vaccine candidate Reuters
07:08PM	Novavax Announces Agreement with Government of New Zealand for 10.7 Million Doses of COVID-19 Vaccine GlobeNewswire
05:00PM	Which COVID Vaccine Stocks Should You Buy Right Now? Motley Fool
09:59AM	10 Healthcare Stocks That Thrived In 2020 Benzinga
06:14AM	3 COVID-19 Vaccine Stocks That Could Be the Biggest Winners in a Post-Pandemic World Motley Fool
05:51AM	3 Stocks That Turned $100,000 Into $1 Million in 2020 Motley Fool
Dec-15-20 06:35AM	These Were the 10 Best Healthcare Stocks of 2020 Motley Fool
06:30AM	4 Reasons to Buy Novavax in 2021 Motley Fool
06:11AM	Could Novavax Be a Millionaire-Maker Stock? Motley Fool
Dec-14-20 12:11PM	Global Stocks Climb Amid U.S. Stimulus Hopes and Start of Covid-19 Vaccine Rollout Barrons.com
09:11AM	Coronavirus update: First Pfizer vaccine shots, U.K. to start human challenge trials Yahoo Finance
09:02AM	The Dow Is Rising. Google Stock Holds Its Ground. Barrons.com
06:04AM	3 COVID Stocks That Are Screaming Buys Motley Fool
Dec-13-20 11:11PM	Novavax Stock: Buy at the High? Motley Fool

Novavax, Inc., together with its subsidiary, Novavax AB, a late-stage biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases. The company's lead vaccine candidates include ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate that in Phase III clinical trial to protect infants from RSV disease through maternal immunization; and NanoFlu, which is in Phase III clinical trial for treating seasonal influenza in older adults. Its lead adjuvant is Matrix-M that is used to enable a vaccine to enhance the amplitude of the immune response and qualitatively change it, and the immune systems attack against microorganisms, as well as to allow immunization with much lower doses of antigen. The company is also developing RSV F vaccine for older adults (60 years and older) that is in Phase II clinical trial, as well as for healthy children between six months to five years of age that is in Phase I clinical trial. In addition, it develops nanoparticle vaccine candidates for clinic testing against ebola virus that is in Phase I clinical trial; and combination respiratory vaccine to protect against influenza and RSV. Further, the company is developing COVID-19 vaccine for coronavirus that causes pneumonia-like symptoms, which is in preclinical stage. It has a partnership agreement with Takeda Pharmaceutical Company Limited for the development, manufacturing, and commercialization of NVX-CoV2373, a COVID-19 vaccine candidate. Novavax, Inc. was founded in 1987 and is headquartered in Gaithersburg, Maryland.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Trizzino John	EVP, CMO and CBO	Jan 07	Sale	124.17	506	62,830	287	Jan 07 07:08 PM
Trizzino John	EVP, CMO and CBO	Jan 05	Option Exercise	18.63	13,756	256,243	17,694	Jan 07 07:08 PM
Trizzino John	EVP, CMO and CBO	Jan 05	Sale	112.00	17,407	1,949,522	287	Jan 07 07:08 PM
YOUNG JAMES F	Director	Dec 31	Option Exercise	51.27	11,000	564,000	11,000	Jan 05 05:38 PM
DOUGLAS RICHARD	Director	Dec 31	Option Exercise	50.00	1,000	50,000	28,500	Jan 05 05:42 PM
YOUNG JAMES F	Director	Dec 31	Sale	113.09	11,000	1,244,015	0	Jan 05 05:38 PM
Erck Stanley C	President and CEO	Nov 16	Option Exercise	37.14	52,317	1,942,801	72,811	Nov 18 06:09 PM
Erck Stanley C	President and CEO	Nov 16	Sale	90.65	52,316	4,742,667	20,495	Nov 18 06:09 PM
Erck Stanley C	President and CEO	Oct 01	Sale	108.57	2	217	20,494	Oct 01 05:39 PM
Trizzino John	EVP, CBO and CFO	Sep 30	Sale	110.22	2,250	248,002	5,087	Oct 01 05:40 PM
Erck Stanley C	President and CEO	Sep 30	Sale	110.23	12,231	1,348,200	20,496	Oct 01 05:39 PM
Herrmann John A III	EVP, Chief Legal Officer	Sep 29	Sale	107.31	18,029	1,934,667	275	Sep 30 09:30 PM
Glenn Gregory M	President, R&D	Sep 29	Sale	107.02	19,949	2,134,844	1,561	Sep 30 09:29 PM
Trizzino John	EVP, CBO and CFO	Sep 29	Sale	107.29	18,321	1,965,630	7,337	Sep 30 09:28 PM
Erck Stanley C	President and CEO	Sep 29	Sale	107.80	4,112	443,267	32,727	Sep 30 09:27 PM
Erck Stanley C	President and CEO	Sep 28	Option Exercise	5.95	50,000	297,500	74,606	Sep 30 09:27 PM
Trizzino John	EVP, CBO and CFO	Sep 28	Option Exercise	5.95	29,600	176,120	53,008	Sep 30 09:28 PM
Glenn Gregory M	President, R&D	Sep 28	Option Exercise	5.95	25,000	148,750	46,510	Sep 30 09:29 PM
Herrmann John A III	EVP, Chief Legal Officer	Sep 28	Option Exercise	5.95	24,750	147,263	43,054	Sep 30 09:30 PM
Glenn Gregory M	President, R&D	Sep 28	Sale	110.30	25,000	2,757,456	21,510	Sep 30 09:29 PM
Trizzino John	EVP, CBO and CFO	Sep 28	Sale	110.30	25,000	2,757,456	25,658	Sep 30 09:28 PM
Erck Stanley C	President and CEO	Sep 28	Sale	110.30	25,000	2,757,456	36,839	Sep 30 09:27 PM
Herrmann John A III	EVP, Chief Legal Officer	Sep 28	Sale	110.30	24,750	2,729,879	18,304	Sep 30 09:30 PM
EVANS GARY C	Director	Aug 18	Option Exercise	31.02	10,500	325,700	332,479	Aug 20 06:09 PM
Glenn Gregory M	President, R&D	Aug 18	Option Exercise	33.56	55,921	1,876,525	57,760	Aug 20 06:14 PM
Herrmann John A III	EVP, Chief Legal Officer	Aug 18	Option Exercise	53.82	46,242	2,488,613	46,517	Aug 20 06:20 PM
MCMANUS MICHAEL A JR	Director	Aug 18	Option Exercise	27.60	8,000	220,800	17,951	Aug 20 06:22 PM
Trizzino John	EVP, CBO and CFO	Aug 18	Option Exercise	50.95	42,788	2,179,986	47,875	Aug 20 06:25 PM
Trizzino John	EVP, CBO and CFO	Aug 18	Sale	148.78	42,788	6,366,182	5,087	Aug 20 06:25 PM
MCMANUS MICHAEL A JR	Director	Aug 18	Sale	146.00	8,000	1,168,000	9,951	Aug 20 06:22 PM
Herrmann John A III	EVP, Chief Legal Officer	Aug 18	Sale	144.33	46,242	6,673,982	275	Aug 20 06:20 PM
Glenn Gregory M	President, R&D	Aug 18	Sale	145.20	55,921	8,119,860	1,839	Aug 20 06:14 PM
EVANS GARY C	Director	Aug 18	Sale	150.44	10,500	1,579,620	321,979	Aug 20 06:09 PM
Glenn Gregory M	President, R&D	Jun 18	Option Exercise	42.20	16,749	706,808	18,588	Jun 22 05:29 PM
Glenn Gregory M	President, R&D	Jun 18	Sale	59.53	16,749	997,103	1,839	Jun 22 05:29 PM
YOUNG JAMES F	Director	Jun 03	Buy	48.83	1,500	73,245	1,500	Jun 05 05:04 PM
Herrmann John A III	SVP, General Counsel	May 18	Option Exercise	26.19	12,961	339,448	7,774	May 20 04:35 PM
Herrmann John A III	SVP, General Counsel	May 18	Sale	49.44	12,961	640,792	275	May 20 04:35 PM
Glenn Gregory M	President, R&D	Jan 31	Buy	3.86	1,250	4,825	1,373	Feb 04 05:11 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience